PharmiWeb.com - Global Pharma News & Resources

Marketing - Press Releases

Date Title Company
13-Feb-2020 Abeona Therapeutics Announces Positive Interim Data from MPS III Gene Therapy Programs Presented at WORLDSymposium™ Abeona Therapeutics Inc.
13-Feb-2020 Sosei Heptares Operational HighlightsSosei Heptares Operational Highlights and Consolidated Results for the 12 Months ended 31 December 2019 and Consolidated Results for the 12 Months ended 31 December 2019 Sosei Heptares
13-Feb-2020 First patient dosed in pivotal phase 3 trial of SNF472 in calciphylaxis Sanifit
13-Feb-2020 The Alliance for Regenerative Medicine Releases Agenda for 2020 Cell & Gene Meeting on the Mediterranean Alliance for Regenerative Medicine
13-Feb-2020 New gene mutation associated with Fabry cardiomyopathy University of Eastern Finland
13-Feb-2020 SCTM roadmap and committed funding will boost Australia’s position in Asia-Pacific stem cell research landscape, says GlobalData GlobalData
13-Feb-2020 New genetic sequencing platform sheds more light on how a household antibacterial kills bacteria Quadram Institute and University of East Anglia
13-Feb-2020 Improvements welcome but NHS 'not out of the woods', says NHS Confederation NHS
13-Feb-2020 XBiotech Announces Preliminary Results of Tender Offer XBiotech Inc
12-Feb-2020 CTMA presents results from clinical trial pre-screening digital solution at ECCO 2020 Clinical Trials Mobile Application (CTMA)
12-Feb-2020 Signant Health Hosts Keynote Panel on eConsent and Patient Engagement, Discusses Sensors and Wearables, and Presents Findings on the Impact of Data at SCOPE 2020 Signant Health
12-Feb-2020 Freeline presents data on its AAV-based gene therapies for Fabry Disease and Gaucher Disease at the 16th annual WORLDSymposium™ Freeline
11-Feb-2020 Orgenesis completes sale of Masthercell subsidiary; receives approximately USD 127 million in net proceeds Orgenesis
11-Feb-2020 Fluidic Analytics launches rapid, easy-to-use protein labeling kit Fluidic Analytics
11-Feb-2020 Pivotal to provide expert clinical research services to Lucid Diagnostics´ clinical studies for its GI in-vitro diagnostics EsoGuard™ and EsoCheck™ to facilitate diagnosis of Barrett’s Esophagus (BE) Pivotal
11-Feb-2020 Biophytis - Protocol Amendment of SARA-INT, a Phase 2b Clinical Trial of Sarconeos (BIO101) in Sarcopenia, Cleared by FDA and AFMPS Biophytis
11-Feb-2020 Scottish Medicines Consortium accepts Revestive® ▼ (teduglutide) for use in NHS Scotland for adult patients with short bowel syndrome Takeda Pharmaceutical Company Limited
11-Feb-2020 Valo Therapeutics Announces New Funding for Immuno-Oncology Trials Valo Therapeutics
11-Feb-2020 Copley Scientific introduces a simple device for inhaled dose dissolution testing Copley Scientific
11-Feb-2020 New SAS Tri-Clover Isolator Head for Microbial Air Sampler Available from Cherwell Laboratories Cherwell Laboratories